Value of High-Sensitive Cardiac Troponin in Predicting Mortality in the Emergency Department

Clinical Laboratory
|February 7, 2017
PubMed

Insights

High-sensitivity cardiac troponin T (hs-cTnT) initial levels alone are insufficient for predicting cardiac mortality in emergency department patients with suspected acute coronary syndrome (ACS). However, hs-cTnT level changes correlate with mortality risk.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Biomarkers

Background:

  • Acute coronary syndrome (ACS) diagnosis in the emergency department (ED) requires accurate risk stratification.
  • High-sensitivity cardiac troponin T (hs-cTnT) is a key biomarker for myocardial injury.

Purpose of the Study:

  • To evaluate the predictive accuracy of initial hs-cTnT levels for mortality in patients with suspected ACS.
  • To determine the utility of hs-cTnT reference values in predicting cardiac and all-cause mortality.

Main Methods:

  • Retrospective analysis of 11,795 patients tested for hs-cTnT in the ED for suspected ACS.
  • Mortality data (all-cause and cardiac) collected from a national mortality registry at one month.
  • Area Under the Curve (AUC) calculated for initial hs-cTnT to assess predictive performance.

Main Results:

  • Initial hs-cTnT showed good predictive value for one-month cardiac mortality (AUC 0.869) and all-cause mortality (AUC 0.861).
  • The upper reference limit (14 ng/L) had 87% sensitivity but only 69% specificity for cardiac mortality.
  • A significant correlation was observed between hs-cTnT level changes (absolute or relative) and mortality rates.

Conclusions:

  • The reference value of initial hs-cTnT alone is not sufficiently accurate for predicting cardiac mortality in ACS patients.
  • Trends in hs-cTnT levels (increases or decreases) are more indicative of mortality risk than a single threshold.
  • Dynamic hs-cTnT measurements may offer improved prognostic value in suspected ACS.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
445
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
670
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
360